» Articles » PMID: 11422110

Ghrelin and Growth Hormone (GH) Secretagogue Receptor (GHSR) MRNA Expression in Human Pituitary Adenomas

Overview
Specialty Endocrinology
Date 2001 Jun 26
PMID 11422110
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The level of growth hormone (GH), growth hormone secretogogue (GHS) and GHS receptor (GHSR) messenger ribonucleic acid (mRNA) expression has been reported as being higher in GH-producing pituitary adenomas than in other types of pituitary adenomas. Recently, ghrelin, an endogenous ligand specific for GHSR, was isolated. Therefore, we attempted to clarify whether ghrelin mRNA is expressed in various types of human pituitary adenoma by competitive reverse transcription-polymerase chain reaction (RT-PCR). We also examined the relationship between the levels of ghrelin or GHSR mRNA and hormonal and tumour characteristics in patients with pituitary adenomas.

Patients: Pituitary adenoma tissue was obtained at surgery from 13 patients with acromegaly, 4 with prolactinomas, 5 with gonadotrophin (Gn)-producing adenomas, 4 with non-functioning adenomas, 2 with ACTH-producing adenomas and 2 with TSH-producing adenomas.

Methods: The expression levels of human ghrelin mRNA and GHSR mRNA were quantified using a competitive RT-PCR method.

Results: Ghrelin mRNA was detected in all pituitary adenoma tissues examined, with the highest mean level detected in non-functioning adenomas, a moderate level in GH-producing adenomas and Gn-producing adenomas, and the lowest level in prolactinomas. The level of ghrelin mRNA expression in GH-producing adenomas correlated negatively with the size of the adenoma (n = 13) (r = - 0.756, P = 0.0028). Furthermore, the mean level of ghrelin mRNA expression in high-grade (III and IV of Hardy classification) GH-producing adenomas was significantly lower than that in low-grade (I and II) GH-producing adenomas (P = 0.0016). GHSR mRNA was also detected in all pituitary adenomas with the highest mean level in GH-producing adenomas, a moderate level in nonfunctioning adenoma, and the lowest level in prolactinoma and Gn-producing adenomas.

Conclusions: Ghrelin mRNA, in addition to GHSR mRNA, is expressed in various types of pituitary adenoma with different levels of expression in each type. Our findings suggest that ghrelin produced in pituitary adenoma may play some role in the mechanism underlying the development of adenoma cells through autocrine and/or paracrine pathways.

Citing Articles

Diverse and Complementary Effects of Ghrelin and Obestatin.

Villarreal D, Pradhan G, Zhou Y, Xue B, Sun Y Biomolecules. 2022; 12(4).

PMID: 35454106 PMC: 9028691. DOI: 10.3390/biom12040517.


Ghrelin Represses Thymic Stromal Lymphopoietin Gene Expression through Activation of Glucocorticoid Receptor and Protein Kinase C Delta in Inflamed Skin Keratinocytes.

Jeong H, Chong H, So J, Jo Y, Yune T, Ju B Int J Mol Sci. 2022; 23(7).

PMID: 35409338 PMC: 8999772. DOI: 10.3390/ijms23073977.


Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy.

Buckinx A, De Bundel D, Kooijman R, Smolders I Biomedicines. 2022; 10(1).

PMID: 35052733 PMC: 8773216. DOI: 10.3390/biomedicines10010053.


Rater Reliability of the Hardy Classification for Pituitary Adenomas in the Magnetic Resonance Imaging Era.

Mooney M, Hardesty D, Sheehy J, Bird C, Chapple K, White W J Neurol Surg B Skull Base. 2017; 78(5):413-418.

PMID: 28875120 PMC: 5582963. DOI: 10.1055/s-0037-1603649.


Microarray technology reveals potentially novel genes and pathways involved in non-functioning pituitary adenomas.

Qiao X, Wang H, Wang X, Zhao B, Liu J Balkan J Med Genet. 2017; 19(2):5-16.

PMID: 28289583 PMC: 5343325. DOI: 10.1515/bjmg-2016-0030.